XSHE
300082
Market cap993mUSD
Dec 05, Last price
10.33CNY
1D
-0.96%
1Q
32.44%
Jan 2017
22.25%
IPO
-64.57%
Name
Liaoning Oxiranchem Inc
Chart & Performance
P/E
—
P/S
1.64
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.41%
Rev. gr., 5y
-7.38%
Revenues
4.29b
+12.43%
Net income
-159m
L-48.45%
CFO
-40m
L
Dividend
May 31, 20220.342 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Liaoning Oxiranchem,Inc. engages in the research and development, production, and sale of high-end and ethylene oxide derivative fine chemicals in China. It offers crystalline silicon cutting liquids for the photovoltaic industry; water reducing agents for cement; polyether monomers; ethylene carbonate products; and polyethylene glycol for use in various applications, including pharmaceutical, personal care, bio-based surfactants, high- performance materials, and special additives. Its products are used in the construction for infrastructure projects, such as high-speed railway lines, subway underground construction, airports and expressways, cleaning agents, washing powders, pharmaceuticals, electronic materials, automotive, textiles, printing inks, and dyes. The company was incorporated in 2000 and is headquartered in Liaoyang, China. Liaoning Oxiranchem,Inc. operates as a subsidiary of Oxiranchem Holding Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||